Ciclesonide: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Ciclesonide. Educational only — not medical advice.

Labeled uses

ALVESCO is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 12 years of age and older. Limitations of Use : ALVESCO is not indicated for the relief of acute bronchospasm. ALVESCO is not indicated for children under 12 years of age.

Source: FDA labeling via NIH DailyMed (set 9f6112fb…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.